Study of Staccato Alprazolam in Subjects with Epilepsy with a Predictable Seizure Pattern

Site Image

Study Overview

You are being asked to participate in this study because you have a diagnosis of focal and/or generalized epilepsy with a documented history of predictable seizure episodes, and experience repeated seizures that require treatment in addition to your maintenance anti-epileptic drugs (AED).

Study Description

The purpose of this research is to test whether a single-use, hand-held, drug-device combination product called STAP-001 is effective, safe and easy to use in a clinical setting. Throughout this consent form STAP-001 (alprazolam and placebo) will be referred to as the study drug. The study drug provides quick delivery of the medication alprazolam to all parts of the body by having subjects breathe in an aerosol form of alprazolam. Alprazolam is approved for the management of anxiety disorder, or the short-term relief of symptoms of anxiety, and for the treatment of panic disorder. Alprazolam is in a class of approved drugs called benzodiazepines that are used for emergency treatment of seizures. However, alprazolam is not yet approved for the treatment of seizures. In this study the device and the use of an aerosol form of alprazolam are experimental, and their use to treat acute seizures has not been approved by the U.S. Food and Drug Administration.

Additional Information:

It is expected that this study will enroll about 115 subjects to take part in this research at approximately 50 sites across the United States, Canada, Australia, and Jamaica. This study involves a stay in an inpatient unit (overnight) for 2 to 8 days. Your participation in this study is expected to last up to 12 weeks total (screening to follow-up). 

  • Study Identifier: 829799

Recruitment Status

Enrolling By Invitation

If you need assistance finding a non-cancer study or if you have any questions, please email

Volunteer Sign up

Volunteer Sign-up

Participate in medical studies to develop new diagnostic and clinical treatments and improve current standards of care.

Sign Up Now!

If you need assistance finding a non-cancer study or if you have any questions, please email